The Final Tally: Dow Goes Sicko Mode, Tech Gets Dumped (PLUS: Trump vs. Elon Cage Match Pt. 2)

By Stocks News   |   1 week ago   |   Stock Market News
The Final Tally: Dow Goes Sicko Mode, Tech Gets Dumped (PLUS: Trump vs. Elon Cage Match Pt. 2)

If you woke up this morning hoping for a chill start to Q3, try again. The first day of H2 2025 just did a full body-slam on the “tech always wins” narrative as the Dow went full Boomer Rage Mode, racking up a 400-point gain to close at 44,494.94. As for the Nasdaq and S&P 500? Close but no cigar. Both indexes toppled -0.82% and -0.11%, respectively as sector rotation went full tilt. If you looked closely, you would’ve seen every tech CEO staring at their charts like they’d just walked in on their parents “roleplaying” retirement. 

Image 1

(Source: Giphy) 

For more context, if you could’ve closed your eyes, and bought anything with “AI” in the name during the first half, you would have outperformed 90% of hedge funds. The Tech Select Sector SPDR Fund soared up a face-melting 25%. But that was the first half. Today, tech got clapped as the rotation was surgical. Traders basically left Nvidia (-3%) and Broadcom (-4%) in a ditch by the side of the road. 

Additionally, Meta (-2.5%) got ghosted, while Microsoft and Alphabet both got dragged -0.22% and -1.08%. As for Palantir, it got pantsed -4% as Netflix (-3.40%), Crowdstrike (-3.38%), and AMD (-4.08%) all pretended to be memestocks, which is entertaining unless you actually own them. On the other hand, not every tech name was taken behind the barn and shot. Apple, surprisingly, and Amazon bolted +1% and +0.49, mostly because Wall Street is high on Siri getting an AI lobotomy from Anthropic. 

Image 2

(Source: Giphy) 

Elsewhere, the Dow was quite literally, “pumping it up”. UnitedHealth (+4.5%), Amgen (+4%), Merck (+3.3%), Johnson & Johnson (+2%) were all up, and all gave “he who makes the disease, makes the cure” energy. Bigly.  But, but, but… hold the fat kid cramp, because diabetes tech stocks like Tandem Diabetes Care (-7.5%) and Beta Bionics (-4.26%) got their clocks cleaned on potential CMS reimbursement changes. Insulet (-4.52%) and Dexcom (-4.25%) also got mauled for good measure. 

Oh, and if you wanted more chaos, Trump and Musk delivered. Tesla (-5%) got absolutely cooked after Trump (fresh off passing a tax-and-spend megabill with a Senate squeaker) told Truth Social that the newly-invented Department of Government Efficiency should look into how many billions Musk’s companies have hoovered up in government cheese. You can’t make this sh*t up LOL. As for IPO’s, Figma got investors bricked up today as it filed for its debut while boasting $749M in revenue with a net loss of $732 million. Sounds legit. 

Image 3

(Source: Giphy) 

So yeah… today was a lot, but it was the official start of a real sector regime change. When the Dow rips and tech tanks this hard, it means the market is taking profits while hedging against AI, political chaos, and a Fed that’s basically freestyling policy. Of course, the only question is, will this rotation stick? Maybe, maybe not. But for now, tech got cooked, and the Dow is roaring. Meaning, keep your head on the swivel for tomorrow's price action and place your bets accordingly. Until next time, friends… 

If you read all of this, congrats for having a 10 second attention span (better than me). As always, here’s our heatmap for today.

Image 4

At the time of publishing, Stocks.News holds positions in Apple, Amazon, Alphabet (Google), Tesla, Meta, Netflix, Microsoft, Merck & Co., and Johnson & Johnson as mentioned in the article. 

Did you find this insightful?

Disclaimer: Information provided is for informational purposes only, not investment advice. We do not recommend buying or selling stocks. Stock price discussions are based on publicly available data. Readers should conduct their own research or consult a financial advisor before investing. Owners of this site have current positions in stocks mentioned thru out the site, Please Read Full Disclaimer for details Here https://app.stocks.news/page/disclaimer